PUBBLICAZIONI GISCAD

pagina 5

· 

Evidence for cure by adjuvant therapy in colon cancer: observations based individual patient data from 20,898 patients on 18 randomized trials

J Clin Oncol. 2009 Feb 20;27(6): 87q2-7

Sargents D, Sobrero A, Grothey A, O'Connel MJ, Buyse M, Andre T,  Zheng Y, Green E, Labianca R, O'Callaghan C, Seitz JF, Francini G, Haller D, Yothers G, Goldberg R, De Gramont A.

· 

Incidence and clinical implications of venous thromboembolism in advanced collect cancer patients: the GISCAD-alternating schedule" study findings

 Eur J Cancer

Mario Mandalà, Sandro Barni, Irene Floriani, Luciano Isa, Giuseppe Fornarini, Maurizio Marangolo, Stefania Mosconi, Domenico Corsi, Eliana Rulli, Luciano Frontini, Enrico Cortesi, Alberto Zaniboni and Roberto Labianca, on behalf of GISCAD (Italian  Group for the Study of Gastrintestinal Cancer).

· 

A randomized phase II study of cetuximab plus gemcitabine/cisplatin combination in advanced pancreatic cancer

The Lancet Oncology, Volume 9, Issue 1, January

Stefano Cascinu, Rossana Berardi, Roberto Labianca, Salvatore Siena, Alfredo Falcone, Enrico Aitini, Sandro Barni, Francesco Di Costanzo, Elisa Dapretto, Giuseppe Tonini, Chiara Pierantoni, Salvatore Artale, Silvia Rota, Irene Floriani, Mario Scartozzi and Alberto Zaniboni on behalf of Italian Group for the Study of Digestive Tract Cancer (GISCAD).

· 

Phase II study of a triplet regimen in advance colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil

Br J Cancer 2004; Oct 18 91(8): 1428-33

Guglielmi A, Barni S, Zaniboni A, Pella Belvedere O, Beretta Gd,  Grossi F, Frontini L, Puglisi F, Labianca R, Sobrero A: the Italian for the Study of Digestive  Tract Cancer  (GISCAD)

· 

Adjuvant therapy for the stage II colon cancer: an elephant in a living

Ann Onco 2004; Sept 15(9): 1310-8

Zaniboni A, Labianca R: GISCAD

· 

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial

J Clin Onco 2005; May 20 23(15): 3509-16

Louvet C, Labianca R, Hammel P, LIEdo G, Zampino MG, Andre T, Zaniboni A, Ducreux M, Aitini E, Taieb J, Farouk R, Lepere C, DeGramont A,: GERCOR/GISCAD.

FONDAZIONE
GISCAD

GRUPPO ITALIANO PER LO STUDIO DEI 

CARCINOMI DELL'APPARATO DIGERENTE

SEDE

Via Gattinoni, 4

20010 Vanzago (MI)

CONTATTI

Tel. 02 84968409

ufficio.operativo@giscad.it

© 2018 Fondazione GISCAD - P.IVA 05396970963